Thermo Fisher Scientific Inc (TMO)
Working capital turnover
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 44,556,000 | 42,879,000 | 42,857,000 | 44,915,000 | 39,211,000 |
| Total current assets | US$ in thousands | 28,707,000 | 22,137,000 | 24,589,000 | 25,229,000 | 20,113,000 |
| Total current liabilities | US$ in thousands | 15,189,000 | 13,332,000 | 14,012,000 | 17,010,000 | 13,436,000 |
| Working capital turnover | 3.30 | 4.87 | 4.05 | 5.46 | 5.87 |
December 31, 2025 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $44,556,000K ÷ ($28,707,000K – $15,189,000K)
= 3.30
Peer comparison
Dec 31, 2025
Company name
Symbol
Working capital turnover
Thermo Fisher Scientific Inc
TMO
3.30
Agilent Technologies Inc
A
3.09
Danaher Corporation
DHR
4.13